Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by themagicboxon Oct 21, 2020 9:20am

152 Views

Post# 31753954

RE:RE:RE:Good Day

Bro there is way too many people that feel that way. Stfu cumster.

A little history on some of your comments
-not sure this was money well spent.) .[on IR stern]

-all about those fake newsletters that come out when a stock is at the low end of a trading range. someone wants in even cheaper.
-will ate go, does not seem to be much interest @39 cents
-6.25% haircut, picked up another 1/3
-bought @40, sold @41.5 i think i will be able to get back in at a lower price after a market corection, mcwhirter also thinks there will be a corection within 1 to 2 months.

glta

The list goes on cumster. So yes please stfu.